Market Closed -
Other stock markets
|
After market 20:59:59 | |||
1.84 EUR | +1.88% | 1.961 | +6.58% |
04-04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
04-03 | AB Science: reconsideration possible for masitinib in ALS | CF |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- AB Stock
- A8D Stock
- Revisions AB Science